Correction to: J. of Cardiovasc. Trans. Res.
10.1007/s12265-019-09950-w
The following are the correction captions for Figures 1–4:
Fig. 1 Monoclonal-protein based MGUS screening protocol. MGUS refers to monoclonal gammopathy of undetermined significance; SPEP, serum protein electrophoresis; IFE, immunofixation electrophoresis.
Fig. 2 Kaplan-Meier survival curves for incidence of MACE in CAD patients with and without MGUS.MACE refers to major adverse cardiac events; CAD, coronary artery disease; MGUS, monoclonal gammopathy of undetermined significance
Fig. 3 The nomogram based on the stepwise Cox regression model to predict the outcomes of CAD patients.MGUS refers to monoclonal gammopathy of undetermined significance; eGFR, estimated glomerular filtration rate; MACE, major adverse cardiac events.
Fig. 4 The calibration curve ofMACE-free survival at 1, 2 and 3 years for CAD patients. Nomogram-predictedMACE-free probability is plotted on the x-axis; actual MACE-free probability is plotted on the y-axis.
The original article has been corrected.
Footnotes
The online version of the original article can be found at 10.1007/s12265-019-09950-w
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.